Study Findings on Drugs and Therapies Reported by a Researcher at Heilongjiang University of Chinese Medicine (Metabolomics for Clinical Biomarker Discovery and Therapeutic Target Identification).

Předmět:
Zdroj: Drug Week; 5/31/2024, p1990-1990, 1p
Abstrakt: A recent report from Heilongjiang University of Chinese Medicine highlights the importance of metabolomics technology in discovering targets of small-molecule metabolites involved in disease phenotype. The study emphasizes the use of mass spectrometry-based metabolomics for analyzing physiological or pathological states and identifying metabolic patterns and targets. The researchers recommend the application of this technology for efficacy evaluation of herbal medicine. This information is valuable for researchers interested in biomarker discovery and therapeutic target identification. [Extracted from the article]
Databáze: Complementary Index